LeMaitre Vascular, Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
LeMaitre Vascular, Inc. (LMAT) holds an ST Score of 53.3 out of 100 (B-), with its strongest factor being Profitability (A+) and its weakest Valuation (D-). Analysts rate LMAT Buy across 20 ratings with a $115.00 average price target (+0.5% vs the current $79.20).
- Strongest
- ProfitabilityA+
- Weakest
- ValuationD-
All factor grades
- ProfitabilityA+
- GrowthB+
- Financial StrengthB
- ForecastB
- MomentumD
- ValuationD-
- Piotroski6/9
Contact
LMAT stock: frequently asked questions
What is LMAT's ST Score?
LeMaitre Vascular, Inc. (LMAT) has an ST Score of 53.3 out of 100, an overall grade of B-. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is LMAT a buy, sell, or hold?
Wall Street's consensus rating on LMAT is Buy based on 20 analyst ratings. Our own ST Score grades it B- (53.3/100). This is data, not investment advice — always do your own research.
What is LMAT's valuation grade?
LeMaitre Vascular, Inc. (LMAT) earns a valuation grade of D-, measured against Medical - Instruments & Supplies peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is LMAT's growth grade?
LeMaitre Vascular, Inc. (LMAT) earns a growth grade of B+, measured against Medical - Instruments & Supplies peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is LMAT's profitability grade?
LeMaitre Vascular, Inc. (LMAT) earns a profitability grade of A+, measured against Medical - Instruments & Supplies peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is LMAT's financial strength grade?
LeMaitre Vascular, Inc. (LMAT) earns a financial strength grade of B, measured against Medical - Instruments & Supplies peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for LMAT?
The average analyst price target for LeMaitre Vascular, Inc. (LMAT) is $115.00 from 20 analysts, which is +0.5% versus the recent price of $79.20.
What is LMAT's Piotroski score?
LeMaitre Vascular, Inc. (LMAT) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.